Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- April 2012
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- Administration, Oral (MeSH)
- Anticoagulants (MeSH)
- Benzimidazoles (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Dabigatran (MeSH)
- Elective Surgical Procedures (MeSH)
- Factor Xa Inhibitors (MeSH)
- Fibrinolytic Agents (MeSH)
- Hemorrhage (MeSH)
- Heparin, Low-Molecular-Weight (MeSH)
- Humans (MeSH)
- Ischemic Attack, Transient (MeSH)
- Medical Records (MeSH)
- Morpholines (MeSH)
- Perioperative Period (MeSH)
- Pyrazoles (MeSH)
- Pyridines (MeSH)
- Pyridones (MeSH)
- Risk Assessment (MeSH)
- Rivaroxaban (MeSH)
- Stroke (MeSH)
- Thiazoles (MeSH)
- Thiophenes (MeSH)
- Thromboembolism (MeSH)
- beta-Alanine (MeSH)